ATLAS CAPITAL ADVISORS LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
ATLAS CAPITAL ADVISORS LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$357
+3.5%
6000.0%0.00%
Q2 2023$345
-18.1%
6000.0%0.00%
Q1 2023$421
-69.0%
6000.0%0.00%
Q4 2022$1,356
-99.9%
6000.0%0.00%
Q3 2022$1,920,000
-15.8%
6000.0%0.00%
Q2 2022$2,280,000
-29.5%
6000.0%0.00%
-100.0%
Q1 2022$3,234,000
-60.1%
6000.0%0.00%0.0%
Q4 2021$8,106,000
-24.8%
6000.0%0.00%
-50.0%
Q3 2021$10,776,000
+4.7%
6000.0%0.00%0.0%
Q2 2021$10,296,000
-14.2%
6000.0%0.00%0.0%
Q1 2021$12,000,000
+17.6%
6000.0%0.00%0.0%
Q4 2020$10,200,000
-26.6%
6000.0%0.00%
-33.3%
Q2 2020$13,896,000
+29.7%
6000.0%0.00%0.0%
Q1 2020$10,710,000
-17.3%
6000.0%0.00%0.0%
Q4 2019$12,951,000
+18.5%
6000.0%0.00%0.0%
Q3 2019$10,929,000
-48.8%
6000.0%0.00%
-57.1%
Q2 2019$21,348,000
-50.5%
600
-53.3%
0.01%
-56.2%
Q1 2019$43,142,000
+2.2%
1,2840.0%0.02%
-5.9%
Q4 2018$42,205,000
-88.3%
1,284
-80.8%
0.02%
-85.8%
Q3 2018$359,896,000
+1140.3%
6,692
+1015.3%
0.12%
+1100.0%
Q2 2018$29,016,000
-54.5%
6000.0%0.01%
-50.0%
Q1 2018$63,756,0006000.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders